NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users

T. WILLEMAN ; N. GRUNDIG ; C. POCHON ; D. MICHELS ; N. CHARPENTIER ; H. EYSSERIC-GUÉRIN ; N. FOUILHE SAM-LAI ; F. STANKE-LABESQUE ; B. REVOL | 2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique

BACKGROUND: 3-methylmethcathinone (3-MMC) has been available on the European drug market for several years, but an increase in its availability seems to have occurred around 2020, associated with reports of harm and death. We aimed to analyze th[...]

Plus d'info

Ajouter à la sélection

Lien externe